Our previous research showed that an LNP-delivered siRNA targeting Cyp2e1 (si-Cyp2e1 LNPs) could effectively inhibit the development of chronic and subacute alcoholic liver disease in mouse models [17,18]. The gene discussed is CYP2E1; the disease is alcoholic liver diseases.